Azithromycin (AZM) has been found to inhibit autophagy and contribute to the development of pulmonary fibrosis by increasing NOX4 ubiquitination through elevated STUB1 protein levels (130). The gene discussed is NOX4; the disease is pulmonary fibrosis.